Schizophrenia

Brain stimulation in people with schizophrenia

19/08/2010 | Mild electrical stimulation to the brain could improve thinking and reduce auditory hallucinations in people with schizophrenia and schizo-affective disorder, researchers from the University of New South Wales have found.


Cannabis shows cognitive benefits in schizophrenics

05/08/2010 | Cognitive performance in patients with schizophrenia is improved if they have a history of using cannabis, but the benefit may be limited to those who started smoking before the age of 16, an Australian study finds.


Music and beta brain-wave activity in psychosis

29/07/2010 | Australian research has shown that listening to music decreases delta, alpha and beta waves on EEG in subjects experiencing an acute psychotic episode.


Genotype defines schizophrenia subgroup

15/07/2010 | A study which grouped schizophrenic patients and controls according to the Zinc Finger Protein 804A (ZNF804A) genotype, then assessed cognitive function, has identified a distinct patient subgroup characterised by spared cognitive ability.


Melbourne study explores brain structure-psychosis link

27/05/2010 | A Melbourne study has concluded that caudate nucleus volume is not a marker of psychosis risk, but more work is needed to analyse changes in its structure over time and its links to prefrontal regions of the brain.


Review confirms benefits of exercise in schizophrenia

20/05/2010 | Psychiatrists need to take responsibility for both the physical and mental well-being of their patients with schizophrenia, say the authors of a review that found regular exercise improved anxiety and depression in these patients.


Study gives snapshot of hospital managed schizophrenia

31/03/2010 | Patients hospitalised with schizophrenia have an average hospital stay of three weeks and a 20% chance of readmission within 28 days, an overview of adult mental health facilities shows.


Gender and age differences in antipsychotic prescribing

30/03/2010 | Atypical antipsychotic are most commonly used to treat schizophrenia in young men and behavioural disturbances in older women with dementia, a study on prescribing trends has found.


Role for raloxifene in postmenopausal women with schizophrenia

24/02/2010 | The selective oestrogen receptor modulator raloxifene may have a role in treating postmenopausal women with schizophrenia, a small pooled analysis finds.


Antipsychotic given green light for teens

04/02/2010 | The Australian Drug Evaluation Committee has backed an application for an antipsychotic drug to be approved for use in children with schizophrenia.


More Schizophrenia news

Most viewed articles this week

Recent comments

Related sites